Cargando…

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma

AIM: The study was designed to mine the expression and roles of IQGAP3 in clear cell renal cell carcinoma (ccRCC). METHODS: Expression profiles and clinical information were obtained from the Cancer Genome Atlas (TCGA) to estimate IQGAP3 expression in ccRCC, its relationship with patients’ clinicopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Quan, Li, Can-Xuan, Long, Dan, Lin, Xiaobin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286744/ https://www.ncbi.nlm.nih.gov/pubmed/34285569 http://dx.doi.org/10.2147/IJGM.S316280

Ejemplares similares

IQGAP3 in clear cell renal cell carcinoma contributes to drug resistance and genome stability
por: Li, Wen, et al.
Publicado: (2022)

KDELC1 and TRMT1 Serve as Prognosis-Related SARS-CoV-2 Proteins Binding Human mRNAs and Promising Biomarkers in Clear Cell Renal Cell Carcinoma
por: Li, Canxuan, et al.
Publicado: (2021)

CARS as a Prognosis Factor in Clear Cell Renal Cell Carcinoma and Its Association with Tumor Immunity
por: Meng, Quan, et al.
Publicado: (2021)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma
por: Chen, Yan-Su, et al.
Publicado: (2016)

AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019)

OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
por: Wei, Shuzhang, et al.
Publicado: (2023)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

IQGAP1 and IQGAP3 serve individually essential roles in normal epidermal homeostasis and tumor progression
por: Monteleon, Christine L., et al.
Publicado: (2015)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth
por: Mao, Huajie, et al.
Publicado: (2023)

TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
por: Xu, Guang-hua, et al.
Publicado: (2018)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma
por: Liu, Zhanxin, et al.
Publicado: (2020)

Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma
por: Li, Cheng Shan, et al.
Publicado: (2021)

IQGAP1 and IQGAP2 are Reciprocally Altered in Hepatocellular Carcinoma
por: White, Colin D, et al.
Publicado: (2010)

A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
por: Li, Rongkang, et al.
Publicado: (2023)

Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma
por: Tang, Gonglin, et al.
Publicado: (2023)

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2019)

MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma
por: Shi, Lei, et al.
Publicado: (2021)

Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma
por: Meng, Wei, et al.
Publicado: (2023)

Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma
por: You, Yongke, et al.
Publicado: (2021)

Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics
por: Li, Wen, et al.
Publicado: (2021)

Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Guo, Tuanjie, et al.
Publicado: (2022)

ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19
por: Yang, Wuping, et al.
Publicado: (2021)

NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
por: Zhou, Jiancheng, et al.
Publicado: (2022)

Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: multi-database and experimental verification
por: Huang, Shuaishuai, et al.
Publicado: (2023)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Park, Ji Young, et al.
Publicado: (2014)

Expression signature of six‐snoRNA serves as novel non‐invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma
por: Zhao, Yanyun, et al.
Publicado: (2020)

The Antithetic Roles of IQGAP2 and IQGAP3 in Cancers
por: Song, Fei, et al.
Publicado: (2023)

Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression
por: Wu, Xiao-rong, et al.
Publicado: (2016)

Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma
por: Wang, Zengzeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hdn5dcboehjl0gsaatgv0tvknb